In his address at the World Health Organization (WHO) conference in Paris, Mr. Dalbow gave the presentation “Device Improvements to Reduce the Number of Under-Doses and Over-Doses and Misaligned Exposures from Therapeutic Radiation.” He has spoken at an FDA annual meeting on Meeting Standardization of Treatment Prescriptions for Oncology, as well as contributed to Computer Assisted Radiology and Surgery white papers on Just in Time Health Care. Dalbow has also managed multiple FDA submissions, including both 501k and PMA submissions. He remains engaged in emerging issues in health care, is dedicated to reducing costs through innovation, and is an industry chair for The Medical Imaging & Technology Alliance (MITA).
CardioWise™ is commercializing patent-pending, non-invasive Cardiac Magnetic Resonance Imaging (cMRI) analysis software that produces a quantified 3D image model of the human heart, called Multiparametric Strain (MPS™) heart analysis. CardioWise heart analysis software combined with cardiac MRI is a single diagnostic test that is able to provide quantitative analysis of the myocardium, arteries and valves with an unprecedented level of detail. It has the opportunity to become the new gold standard of care for heart health analysis. CardioWise™ is a VIC Technology Venture Development™ portfolio company.
Read the full story at http://www.prweb.com/releases/2013/3/prweb10535481.htm.
Copyright©2012 Vocus, Inc.
All rights reserved